13F-HR filed by MPM BIOIMPACT LLC
MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 37 holding rows worth $1,639,957,110.
- Accession
- 0001193125-26-352199
- Filer
- CIK 1687078
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 37 entries on the cover page, a total value of $1,639,957,110 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,639,957,110 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 9,731,341 | $177,207,720 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 4,835,872 | $155,860,155 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,386,174 | $110,519,653 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 492,483 | $92,232,216 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 771,028 | $67,040,885 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,620,780 | $65,852,291 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,122,731 | $63,782,348 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 3,666,284 | $60,127,058 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 3,073,577 | $57,322,211 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 2,019,020 | $56,815,223 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 1,225,855 | $56,462,881 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 1,418,215 | $47,354,199 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 2,415,672 | $45,197,223 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 336,347 | $44,821,601 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,922,093 | $42,689,686 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 420,002 | $40,941,795 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 1,667,661 | $40,874,371 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 933,415 | $34,349,672 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 1,606,967 | $31,287,647 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 204,027 | $31,179,406 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 4,500,000 | $30,645,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,333,523 | $29,150,813 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 1,161,081 | $28,098,160 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 4,472,843 | $26,389,774 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 92,638 | $25,146,585 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 723,314 | $23,666,834 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 1,936,291 | $22,267,347 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 137,208 | $21,127,974 | dollars as filed | |
| FORTE BIOSCIENCES INC | 34962G208 | COMMON STOCK | 987,448 | $20,983,270 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,882,162 | $20,383,814 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 322,007 | $20,267,121 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 3,544,354 | $20,238,261 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 202,114 | $14,188,403 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 1,253,053 | $9,222,470 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,042,467 | $5,514,650 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,299,046 | $719,542 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 80,142 | $28,851 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-352199 | this filing | 2026-08-14 | acceptance time not in the bulk data set |